Collegium Pharmaceutical, Inc. (COLL)
48.35
-0.51
(-1.04%)
USD |
NASDAQ |
Dec 11, 16:00
48.35
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Free Cash Flow: 289.30M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 234.54M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Altimmune, Inc. | -66.66M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| Viking Therapeutics, Inc. | -224.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 78.44M |
| Cash from Investing (Quarterly) | -30.87M |
| Cash from Financing (Quarterly) | -14.82M |
| Free Cash Flow Per Share (Quarterly) | 1.984 |
| Free Cash Flow to Equity (Quarterly) | 93.72M |
| Free Cash Flow to Firm (Quarterly) | 94.04M |
| Free Cash Flow Yield | 15.80% |